Wordt geladen...
Short peptide pharmacophores developed from protein phosphatase-1 disrupting peptides (PDPs)
PP1 is a major phosphoserine/threonine-specific phosphatase that is involved in diseases such as heart insufficiency and diabetes. PP1-disrupting peptides (PDPs) are selective modulators of PP1 activity that release its catalytic subunit, which then dephosphorylates nearby substrates. Recently, PDPs...
Bewaard in:
| Gepubliceerd in: | Bioorg Med Chem |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2022
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7613447/ https://ncbi.nlm.nih.gov/pubmed/35525109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2022.116785 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|